论文部分内容阅读
慢性阻塞性肺疾病96例,其中40例采用藻酸双酯钠(PSS)0.2g静滴,qd;30例采用片剂PSS0.1g,tid;po;26例采用肝素100mg静滴,qd;3组均以10d为一个疗程。结果:PSS静滴组、口服组、与肝素组总有效率依次为90％,87％,92％,无明显差异。PSS不良反应明显小于肝素。
96 cases of chronic obstructive pulmonary disease, including 40 cases of sodium alginate (PSS) 0.2g intravenous infusion, qd; 30 cases using tablet PSS0.1g, tid; po; 26 cases of heparin 100mg intravenous infusion, qd; 3 groups were 10d for a course of treatment. Results: The total effective rate of PSS intravenous drip group, oral group and heparin group was 90%, 87% and 92% respectively, with no significant difference. Adverse reactions to PSS were significantly less than heparin.